Stellantis announces termination of jeep venture with China's GAC
DeeperDive is a beta AI feature. Refer to full articles for the facts.
STELLANTIS announced the “orderly termination” of its loss-making joint venture with Chinese carmaker GAC, which has been producing Jeep vehicles, after it failed in its attempt to take control of the business.
Stellantis will recognise a non-cash impairment of around 297 million euros (S$420.8 million) for its first half-year results, the company said.
Stellantis’ shares in Milan and Paris were both up by just over 1 per cent in early session trading.
Several joint ventures between international automakers and local partners have come under pressure in China, where competition has been heating up while lockdowns in response to the Covid-19 pandemic have also impacted production and sales.
Stellantis had previously announced its intention to take a 75 per cent stake in the joint business with GAC in January - a plan that was immediately rebuked by its Chinese counterpart.
Stellantis on Monday blamed the end of the partnership on a “lack of progress” regarding those plans.
Navigate Asia in
a new global order
Get the insights delivered to your inbox.
“The Jeep brand will continue to strengthen its product offering in China with an enhanced electrified line-up of imported vehicles meant to exceed Chinese customer expectations,” Stellantis added.
China has been a weak spot for Stellantis - the world’s fourth-biggest carmaker - where Stellantis has had a market share of less than 1 per cent. REUTERS
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
From 1MDB to ‘corporate mafia’: Is Malaysia facing a new governance test?
Higher costs, lower returns: Why are Singaporeans still betting on real estate?
South-east Asian markets account for 8.8% of global capital inflows from 2021 to 2024: report
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant